MKI67 and breast carcinoma: Using immunocytochemical analysis the MCF-7 human breast cancer cell line has been classified as a breast carcinoma luminal subtype expressing the estrogen receptor (ER) and progesterone receptor (PR) without HER2 overexpression and moderate levels of Ki-67 [26].